“The goal is to create a blood test that can be used in clinics to complement CT imaging assessment of lung nodules for cancer risk," UCLA radiologist Denise Aberle noted.
The self-expanding valve, already approved by the FDA, was designed with three gold markers to boost implanter efficiency, an updated catheter tip and a more flexible delivery system.